Cohen Raymond W insider trades
Cohen Raymond W has filed 19 Form 4s with the SEC that we hold, for AXNX (Chief Executive Officer, Director), Kestra Medical Technologies, LTD. (KMTS) (Director), RxSight, Inc. (RXST) (Director) and Biolife Solutions INC (BLFS) (Director), among 5 companies in all. Across all of them we count 2 purchases worth $488.8K and 21 sales worth $21.4M reported on Form 4. In the last 12 months: 1 purchase ($199.8K) and 1 sale ($97.5K). The largest single trade was a sale of 50,000 shares of AXNX worth $3.9M, dated 2021-09-09. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-14 and the latest 2026-10-01.
AXNX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-09 | S, sale reported on Form 4 | 50,000 | $3.9M | 2021-09-13 |
| 2022-02-03 | S, sale reported on Form 4 | 1,779 | $87.2K | 2022-02-03 |
| 2022-02-03 | S, sale reported on Form 4 | 33,336 | $1.6M | 2022-02-03 |
| 2022-03-14 | S, sale reported on Form 4 | 17,787 | $896.8K | 2022-03-16 |
| 2022-03-14 | S, sale reported on Form 4 | 2,100 | $107.9K | 2022-03-16 |
| 2022-03-14 | S, sale reported on Form 4 | 16,900 | $926.1K | 2022-03-16 |
| 2022-03-14 | S, sale reported on Form 4 | 11,232 | $606.0K | 2022-03-16 |
| 2022-03-14 | S, sale reported on Form 4 | 1,981 | $104.3K | 2022-03-16 |
| 2022-03-29 | S, sale reported on Form 4 | 50,000 | $3.0M | 2022-03-31 |
| 2022-08-08 | S, sale reported on Form 4 | 18,100 | $1.3M | 2022-08-10 |
| 2022-08-08 | S, sale reported on Form 4 | 1,776 | $128.0K | 2022-08-10 |
| 2022-08-08 | S, sale reported on Form 4 | 12,032 | $862.1K | 2022-08-10 |
| 2022-08-08 | S, sale reported on Form 4 | 12,092 | $851.3K | 2022-08-10 |
| 2023-01-13 | S, sale reported on Form 4 | 18,684 | $1.2M | 2023-01-18 |
| 2023-01-13 | S, sale reported on Form 4 | 22,052 | $1.5M | 2023-01-18 |
| 2023-01-31 | S, sale reported on Form 4 | 13,872 | $848.6K | 2023-02-02 |
| 2023-01-31 | S, sale reported on Form 4 | 9,032 | $552.0K | 2023-02-02 |
| 2023-02-01 | S, sale reported on Form 4 | 6,932 | $423.0K | 2023-02-02 |
| 2023-02-01 | S, sale reported on Form 4 | 1,185 | $71.6K | 2023-02-02 |
| 2024-01-31 | S, sale reported on Form 4 | 35,161 | $2.4M | 2024-02-02 |
Kestra Medical Technologies, LTD. (KMTS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-07 | P, purchase reported on Form 4 | 17,000 | $289.0K | 2025-09-08 |
| 2026-03-26 | P, purchase reported on Form 4 | 10,000 | $199.8K | 2026-03-30 |
| 2026-09-30 | S, sale reported on Form 4 | 3,330 | $97.5K | 2026-10-01 |
RxSight, Inc. (RXST)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Biolife Solutions INC (BLFS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
InspireMD, Inc. (NSPR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1258288) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms